(Q34488888)

2 August 2017

1 reference

title

Systematic review: Complementary and alternative medicine in the irritable bowel syndrome (English)

1 reference

2 August 2017

1 reference

irritable bowel syndrome

1 reference

Hussain Z

1

1 reference

PubMed ID

16441466

2 August 2017

Quigley EM

series ordinal

2

1 reference

PubMed ID

16441466

2 August 2017

language of work or name

English

0 references

publication date

1 February 2006

1 reference

Alimentary Pharmacology & Therapeutics

2 August 2017

1 reference

2 August 2017

23

1 reference

2 August 2017

4

1 reference

2 August 2017

465-471

1 reference

Racing toward the integration of complementary and alternative medicine: a marathon or a sprint?

2 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02776.X

Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02776.X

Treatment of irritable bowel syndrome with Chinese herbal medicine: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02776.X

Complementary and alternative medicine in gastroenterology: the good, the bad, and the ugly

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02776.X

Evaluation of randomized controlled trials on complementary and alternative medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02776.X

Do certain countries produce only positive results? A systematic review of controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02776.X

The Incidence of self-prescribed oral complementary and alternative medicine use by patients with gastrointestinal diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02776.X

Predictors of conventional and alternative health care seeking for irritable bowel syndrome and functional dyspepsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02776.X

The placebo effect in irritable bowel syndrome trials: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02776.X

Defining the predictors of the placebo response in irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02776.X

The effects of relaxation response meditation on the symptoms of irritable bowel syndrome: results of a controlled treatment study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02776.X

A one year follow-up of relaxation response meditation as a treatment for irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02776.X

Hypnotherapy in irritable bowel syndrome: a large-scale audit of a clinical service with examination of factors influencing responsiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02776.X

Cognitive change in patients undergoing hypnotherapy for irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02776.X

Hypnosis and Irritable Bowel Syndrome: A Review of Efficacy and Mechanism of Action

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02776.X

Use of complementary therapies by patients with IBD may indicate psychosocial distress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02776.X

Peppermint oil for irritable bowel syndrome: a critical review and metaanalysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02776.X

A systematic review of alternative therapies in the irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02776.X

Food elimination based on IgG antibodies in irritable bowel syndrome: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02776.X

The use of probiotics in functional bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02776.X

Abnormal colonic fermentation in irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02776.X

A randomized controlled trial of a probiotic, VSL#3, on gut transit and symptoms in diarrhoea-predominant irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02776.X

A randomized controlled trial of a probiotic combination VSL# 3 and placebo in irritable bowel syndrome with bloating

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02776.X

Acupuncture for irritable bowel syndrome: a blinded placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02776.X

Is the increasing use of evidence-based pharmacotherapy causing the renaissance of complementary medicine?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02776.X

10.1111/J.1365-2036.2006.02776.X

21 January 2018

Identifiers

DOI

1 reference

2 August 2017

1 reference

PubMed ID

16441466